Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-20-000006
Filing Date
2020-02-13
Accepted
2020-02-13 16:21:23
Documents
1
Period of Report
2020-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158162886617100.html 4  
1 FORM 4 wf-form4_158162886617100.xml 4 7562
  Complete submission text file 0001439222-20-000006.txt   8985
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 SIDNEY STREET, 2ND FLOOR CAMBRIDGE MA 02139
Business Address
Bowden Christopher (Reporting) CIK: 0001608601 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 20610883